What's New

Downloadable Resource
Hemophilia Gene Therapy Resource Guide
Gene therapy will become a powerful approach in the management of hemophilia and could offer a definitive cure. Our resource guide explores ongoing clinical trial results and emerging data.

Newsletter
New and Emerging Therapies for Relapsed/Refractory Follicular Lymphoma
Loretta J. Nastoupil, MD; Catherine S. Diefenbach, MD

Webinar Replay
Latest Advances in Gene Therapy for Hemophilia
Steven W. Pipe, MD

Newsletter
Frontline Treatment of DLBCL: Practice Implications
Andrew D. Zelenetz, MD, PhD

Newsletter
Treating Relapsed/Refractory DLBCL: Practice Implications
Matthew Lunning, DO, FACP

Newsletter
Diagnosis and Management of Pediatric and Adult Patients with Immune Thrombocytopenia
Hanny Al-Samkari, MD and Michele P. Lambert, MD, MSTR

Newsletter
Addressing Disparities in Care for Patients with DLBCL
Loretta J. Nastoupil, MD

CE Education
Faculty Roundtable on CAR T-cell Therapies, Bispecific Antibodies & Antibody-Drug Conjugates in FL
Loretta J. Nastoupil, MD and Catherine S. Diefenbach, MD

CE Education
Selecting Optimal Therapy for Patients with Hemophilia
Meera B. Chitlur, MD

CE Education
Improving Outcomes for Pediatric and Adult Patients with Immune Thrombocytopenia
Hanny Al-Samkari, MD and Michele P. Lambert, MD, MSTR

Newsletter
Key Facts in Diagnosing and Managing VWD
Angela C. Weyand, MD

Newsletter
Diagnosing and Managing Pediatric and Young Adult Patients Living with VWD
Sarah O'Brien, MD

CE Education
Improving the Spectrum of Care for Patients with Diffuse Large B-cell Lymphoma
James O. Armitage, MD; John P. Leonard, MD; and Jason Westin, MD, MS, FACP

Newsletter
Prophylaxis as a New Strategy for the Management of Patients with VWD
Miguel A. Escobar, MD

CE Education
New Directions in the Frontline Treatment of DLBCL: Implications for Practice
James O. Armitage, MD; and Andrew D. Zelenetz, MD, PhD

CE Education
New Directions in the Treatment of Relapsed/Refractory DLBCL: Implications for Practice
James O. Armitage, MD; and Matthew Lunning, DO, FACP

Newsletter
Recognizing and Treating von Willebrand's Disease in Women
Miguel A. Escobar, MD

CE Education
Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice
James O. Armitage, MD; and Gilles Salles, MD, PhD

CE Education
Prophylaxis in Patients with Von Willebrand Disease: Expert Perspectives and Shared Experiences
Robert F. Sidonio, Jr., MD, Miguel A. Escobar, MD, Angela C. Weyand, MD